Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API


logo
TRex Bio logo

TRex Bio

Recent Finacing

Series B ext

Recent Raise

$50M

TRex Bio develops therapies that activate regulatory T cells to treat immune-mediated diseases such as atopic dermatitis.

California, United States
11-50
Private
trex.bio
PitchBook

Highlights

Focus Areas

Bioinformatics
Biopharma
Biotechnology

Recent Investors

Alexandria Venture Investments logo
Eli Lilly and Company logo
SV Health Investors logo
Johnson & Johnson Innovation logo
Pfizer Ventures logo
Polaris Partners logo
Delos Capital logo
A
Agent Capital logo
Janus Henderson Investors logo
Laurion Capital Management logo

Financials

$219M

Total Raised

4

Funding rounds

11

Investors


Team

Upgrade to view the team

See the team members at TRex Bio.